NextPharma is a leading European Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with sites located in Germany, France, Finland, Norway and the UK, and with healthcare logistics services in the DACH region. With expertise in solids, semi solids and non-sterile and ophthalmic liquids, the company provides services from pharmaceutical development, clinical supplies, scale-up and process validation through to commercial manufacturing for a large range of dosage forms including tablets, capsules, softgels, granules, powders, pellets, gels, creams, sprays and syrups. Each of our sites is a centre of excellence for both development and commercial capabilities with some specific niche expertise and capabilities such as high potent, hormone, beta lactams, controlled drugs, lipid based and modified release formulations, with Soft gel, Soft vegetal and liquid filled hard shell technologies.
NextPharma can also supply a wide range of nutritional products in dosage forms such as tablets, chewable tablets, liquids, softgel capsules and ampoules. Our production sites, based in Europe, are to GMP standards and meet European food regulation standards. We can also provide formulation development and regulatory services to help our wide customer base meet the requirements of the fast growing global food supplement market.